The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001130987.2(DYSF):c.1350del (p.Phe451fs)

CA1705706

551669 (ClinVar)

Gene: DYSF (HGNC:8291)
Condition: autosomal recessive limb-girdle muscular dystrophy (MONDO:0015152)
Inheritance Mode: Autosomal recessive inheritance
UUID: 4c9547ca-5c55-4e70-9c57-f110c35e4994
Approved on: 2025-09-17
Published on: 2025-10-09

HGVS expressions

NM_001130987.2(DYSF):c.1350del (p.Phe451fs)
NM_001130987.2:c.1350del
NC_000002.12:g.71528371del
CM000664.2:g.71528371del
NC_000002.11:g.71755501del
CM000664.1:g.71755501del
NC_000002.10:g.71609009del
NG_008694.1:g.79749del
ENST00000258104.8:c.1254del
ENST00000410020.8:c.1350del
ENST00000258104.7:c.1254del
ENST00000394120.6:c.1257del
ENST00000409366.5:c.1257del
ENST00000409582.7:c.1347del
ENST00000409651.5:c.1350del
ENST00000409744.5:c.1257del
ENST00000409762.5:c.1347del
ENST00000410020.7:c.1350del
ENST00000410041.1:c.1350del
ENST00000413539.6:c.1347del
ENST00000429174.6:c.1254del
NM_001130455.1:c.1257del
NM_001130976.1:c.1254del
NM_001130977.1:c.1254del
NM_001130978.1:c.1254del
NM_001130979.1:c.1347del
NM_001130980.1:c.1347del
NM_001130981.1:c.1347del
NM_001130982.1:c.1350del
NM_001130983.1:c.1257del
NM_001130984.1:c.1257del
NM_001130985.1:c.1350del
NM_001130986.1:c.1257del
NM_001130987.1:c.1350del
NM_003494.3:c.1254del
NM_001130455.2:c.1257del
NM_001130976.2:c.1254del
NM_001130977.2:c.1254del
NM_001130978.2:c.1254del
NM_001130979.2:c.1347del
NM_001130980.2:c.1347del
NM_001130981.2:c.1347del
NM_001130982.2:c.1350del
NM_001130983.2:c.1257del
NM_001130984.2:c.1257del
NM_001130985.2:c.1350del
NM_001130986.2:c.1257del
NM_003494.4:c.1254del
More

Pathogenic

Met criteria codes 4
PM3_Supporting PM2_Supporting PP4_Strong PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Limb Girdle Muscular Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DYSF Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Limb Girdle Muscular Dystrophy VCEP
The NM_003494.4: c.1254del p.(Phe419LeufsTer41) variant in DYSF, which is also known as NM_001130987.2: c.1350del p.(Phe451LeufsTer41), is a frameshift variant expected to introduce a premature stop codon in exon 15/55, leading to nonsense mediated decay in a gene in which loss of function is a known mechanism of disease (PVS1). In the literature, this variant has also been described as p.(Pro418ProfsTer123). This variant has been reported in at least three patients with features consistent with LGMD (PMID: 27647186, 26404900, 26404900), including in a homozygous state without reported familial consanguinity (0.5 pts, PMID: 17994539; PM3_Supporting). This homozygous individual had both progressive limb girdle muscle weakness and absent dysferlin expression in skeletal muscle via both immunohistochemistry and Western blot (PMID: 17994539; PP4_Strong). The highest population allele frequency for this variant is 8.475e-7 in gnomAD v4.1.0 (1/1180008 European (non-Finnish) alleles), which is less than the threshold of 0.0001 for PM2_Supporting, meeting this criterion (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 09/17/2025): PVS1, PM3_Supporting, PP4_Strong, PM2_Supporting.
Met criteria codes
PM3_Supporting
This variant has been reported in at least three patients with features consistent with LGMD (PMID: 27647186, 26404900, 26404900), including in a homozygous state without reported familial consanguinity (0.5 pts, PMID: 17994539; PM3_Supporting).
PM2_Supporting
The highest population allele frequency for this variant is 8.475e-7 in gnomAD v4.1.0 (1/1180008 European (non-Finnish) alleles), which is less than the threshold of 0.0001 for PM2_Supporting, meeting this criterion (PM2_Supporting).
PP4_Strong
This homozygous individual had both progressive limb girdle muscle weakness and absent dysferlin expression in skeletal muscle via both immunohistochemistry and Western blot (PMID: 17994539; PP4_Strong).
PVS1
The NM_003494.4: c.1254del p.(Phe419LeufsTer41) variant in DYSF, which is also known as NM_001130987.2:c.1350del (p.Phe451LeufsTer41), is a frameshift variant expected to introduce a premature stop codon in exon 15/55, leading to nonsense mediated decay in a gene in which loss of function is a known mechanism of disease (PVS1). In the literature, this variant has also been described as p.(Pro418ProfsTer123).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.